Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells
- PMID: 22751989
- DOI: 10.3892/ijo.2012.1534
Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells
Abstract
Sirtuins (SIRTs), NAD+-dependent class III histone deacetylases (HDACs), play an important role in the regulation of cell division, survival and senescence. Although a number of effective SIRT inhibitors have been developed, little is known about the specific mechanisms of their anticancer activity. In this study, we investigated the anticancer effects of sirtinol, a SIRT inhibitor, on MCF-7 human breast cancer cells. Apoptotic and autophagic cell death were measured. Sirtinol significantly inhibited the proliferation of MCF-7 cells in a concentration-dependent manner. The IC50 values of sirtinol were 48.6 µM (24 h) and 43.5 µM (48 h) in MCF-7 cells. As expected, sirtinol significantly increased the acetylation of p53, which has been reported to be a target of SIRT1/2. Flow cyto-metry analysis revealed that sirtinol significantly increased the G1 phase of the cell cycle. The upregulation of Bax, downregulation of Bcl-2 and cytochrome c release into the cytoplasm, which are considered as mechanisms of apoptotic cell death, were observed in the MCF-7 cells treated with sirtinol. The annexin V-FITC assay was used to confirm sirtinol-induced apoptotic cell death. Furthermore, the expression of LC3-II, an autophagy-related molecule, was significantly increased in MCF-7 cells after sirtinol treatment. Autophagic cell death was confirmed by acridine orange and monodansylcadaverine (MDC) staining. Of note, pre-treatment with 3-methyladenine (3-MA) increased the sirtinol-induced MCF-7 cell cytotoxicity, which is associated with blocking autophagic cell death and increasing apoptotic cell death. Based on our results, the downregulation of SIRT1/2 expression may play an important role in the regulation of breast cancer cell death; thus, SIRT1/2 may be a novel molecular target for cancer therapy and these findings may provide a molecular basis for targeting SIRT1/2 in future cancer therapy.
Similar articles
-
Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding.Int J Biol Sci. 2016 Dec 6;12(12):1555-1567. doi: 10.7150/ijbs.13833. eCollection 2016. Int J Biol Sci. 2016. PMID: 27994519 Free PMC article.
-
Cladosporol A triggers apoptosis sensitivity by ROS-mediated autophagic flux in human breast cancer cells.BMC Cell Biol. 2017 Jul 20;18(1):26. doi: 10.1186/s12860-017-0141-0. BMC Cell Biol. 2017. PMID: 28728544 Free PMC article.
-
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.Mol Cancer Ther. 2010 Apr;9(4):844-55. doi: 10.1158/1535-7163.MCT-09-0971. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371709
-
Autophagic and apoptotic effects of HDAC inhibitors on cancer cells.J Biomed Biotechnol. 2011;2011:830260. doi: 10.1155/2011/830260. Epub 2011 May 18. J Biomed Biotechnol. 2011. PMID: 21629704 Free PMC article. Review.
-
Vorinostat in autophagic cell death: A critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention.Drug Discov Today. 2022 Jan;27(1):269-279. doi: 10.1016/j.drudis.2021.08.004. Epub 2021 Aug 13. Drug Discov Today. 2022. PMID: 34400351 Free PMC article. Review.
Cited by
-
Autophagy attenuates the catabolic effect during inflammatory conditions in nucleus pulposus cells, as sustained by NF-κB and JNK inhibition.Int J Mol Med. 2015 Sep;36(3):661-8. doi: 10.3892/ijmm.2015.2280. Epub 2015 Jul 10. Int J Mol Med. 2015. PMID: 26165348 Free PMC article.
-
MHY2245, a Sirtuin Inhibitor, Induces Cell Cycle Arrest and Apoptosis in HCT116 Human Colorectal Cancer Cells.Int J Mol Sci. 2022 Jan 29;23(3):1590. doi: 10.3390/ijms23031590. Int J Mol Sci. 2022. PMID: 35163511 Free PMC article.
-
Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes.Cells. 2019 Dec 17;8(12):1656. doi: 10.3390/cells8121656. Cells. 2019. PMID: 31861179 Free PMC article. Review.
-
p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death.Int J Mol Sci. 2019 May 15;20(10):2415. doi: 10.3390/ijms20102415. Int J Mol Sci. 2019. PMID: 31096697 Free PMC article. Review.
-
Isolation of a novel bio-peptide from walnut residual protein inducing apoptosis and autophagy on cancer cells.BMC Complement Altern Med. 2015 Nov 23;15:413. doi: 10.1186/s12906-015-0940-9. BMC Complement Altern Med. 2015. PMID: 26593407 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous